Gainers
- ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 176.5% to close at $31.00 on Thursday after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to shareholders.
- Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) gained 51% to settle at $27.03 after the FDA Advisory Committee voted that available evidence of effectiveness is sufficient to support approval of AMX0035 for the treatment of ALS. Citigroup (NYSE:C) and SVB Leerink raised their price targets.
- Rubius Therapeutics, Inc. (NASDAQ: RUBY) climbed 48.6% to close at $1.29 after declining 11% on Wednesday. Rubius Therapeutics, last month, posted a Q2 loss of $0.49 per share.
- Benitec Biopharma Inc. (NASDAQ: BNTC) shares gained 33% to close at $0.7880. The company, last week, filed its annual report on Form 10-K for the quarter ended June 30, 2022, with the U.S. Securities and Exchange Commission.
- Marker Therapeutics, Inc. (NASDAQ: MRKR) rose 31.5% to close at $0.3999 after the company's Phase 2 study of multi-tumor-associated antigen-specific T cell therapy for relapsed/refractory AML appeared on the FDA's Orphan Products Grants Program site.
- Palatin Technologies, Inc. (NYSE: PTN) gained 26.2% to close at $6.31 after the company announced the initiation of patient recruitment for its Phase 2 study evaluating oral PL8177 in ulcerative colitis.
- LifeStance Health Group, Inc. (NASDAQ: LFST) jumped 25.8% to close at $9.57. LifeStance Health named Ken Burdick as CEO and Chairman.
- T Stamp Inc. (NASDAQ: IDAI) gained 25% to settle at $1.85.
- Asana, Inc. (NYSE: ASAN) shares gained 24.8% to close at $23.76 after the company reported better-than-expected results for its second quarter and issued a strong sales guidance. RBC Capital and Citigroup raised their price targets on the stock.
- Relay Therapeutics, Inc. (NASDAQ: RLAY) gained 23.8% to close at $31.37. Relay Therapeutics announced efficacy of RLY-4008, a highly selective FGFR2 inhibitor in patients with a FGFR2-fusion or rearrangement FGFR inhibitor-naïve cholangiocarcinoma: ReFocus trial.
- Revance Therapeutics, Inc. (NASDAQ: RVNC) gained 21.6% to close at $25.30 after the company announced FDA approval of DAXXIFY for injection for temporary improvement of moderate to severe frown lines.
- SPAR Group, Inc. (NASDAQ: SGRP) rose 21.3% to close at $1.54 after the company's board of directors initiated a process to evaluate potential strategic alternatives including a sale, merger or other strategic transaction.
- Allarity Therapeutics, Inc. (NASDAQ: ALLR) rose 20.4% to settle at $1.30.
- Eve Holding, Inc. (NYSE: EVEX) jumped 20% to close at $7.39. United reported a $15 million investment in Eve Air Mobility and a conditional purchase agreement for 200 four-seat electric aircraft plus 200 options.
- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) climbed 18.9% to settle at $708.85 after the company announced that the primary endpoints were met in two pivotal trials investigating novel aflibercept 8 mg with 12- and 16-week dosing regimens in patients with diabetic macular edema and wet age-related macular degeneration.
- Eyenovia, Inc. (NASDAQ: EYEN) gained 18.6% to close at $2.48.
- VistaGen Therapeutics, Inc. (NASDAQ: VTGN) jumped 18.4% to close at $0.1953 after the company announced the completion of an interim analysis of its PALISADE-2 Phase 3 clinical trial of PH94B.
- IVERIC bio, Inc. (NASDAQ: ISEE) gained 18.3% to settle at $17.68 after Stifel maintained a Buy rating on the stock and raised its price target from $28 to $35.
- First High-School Education Group Co., Ltd. (NYSE: FHS) gained 17% to close at $0.75.
- Lyft , Inc. (NASDAQ: NASDAQ:LYFT) gained 16.9% to close at $17.17 amid vague rumors from a questionable source mentioning the company.
- NantHealth, Inc. (NASDAQ: NH) jumped 16.4% to close at $0.4788.
- Venus Concept Inc. (NASDAQ: VERO) gained 15.8% to close at $0.7473.
- Annovis Bio, Inc. (NYSE: ANVS) climbed 15.7% to settle at $12.19 after HC Wainwright & Co initiated coverage on the stock with a Buy rating and announced a $40 price target.
- Phreesia, Inc. (NYSE: PHR) rose 15.6% to close at $27.64 after the company reported better-than-expected Q2 sales results and raised the low-end of its FY23 sales guidance.
- Tandem Diabetes Care, Inc. (NASDAQ: TNDM) jumped 15.3% to close at $52.61.
- AeroVironment, Inc. (NASDAQ: AVAV) gained 14.9% to close at $101.87 after reporting upbeat quarterly sales.
- Immunocore Holdings plc (NASDAQ: IMCR) rose 14.9% to settle at $57.44 after Ladenburg Thalmann initiated coverage on the stock with a Buy rating and announced an $82 price target.
- Terns Pharmaceuticals, Inc. (NASDAQ: TERN) gained 14.7% to close at $4.36.
- Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) rose 14.4% to close at $23.86. Rhythm Pharmaceuticals announced new employment inducement grants. Goldman Sachs (NYSE:GS) maintained Rhythm Pharmaceuticals with a Buy and raised the price target from $28 to $31.
- Cazoo Group Ltd (NYSE: CZOO) gained 13.5% to close at $0.6921. The company announced it will wind down operations in mainland Europe to focus on core UK market.
- PROCEPT BioRobotics Corporation (NASDAQ: PRCT) jumped 11.3% to close at $49.93.
- Rivian Automotive, Inc. (NASDAQ: RIVN) gained 10.9% to close at $36.88 after the company and Mercedes-Benz Vans signed a Memorandum of Understanding for a strategic partnership.
- John Wiley & Sons, Inc. (NYSE: WLY) gained 10.8% to settle at $46.08. CJS Securities upgraded John Wiley & Sons from Market Perform to Market Outperform.
- Allego N.V. (NYSE: ALLG) rose 9.6% to close at $4.33. Allego recently announced first half financial results and 2022 revenue expectations.
- Heliogen, Inc. (NYSE: HLGN) rose 9.5% to close at $2.42.
- Albireo Pharma, Inc. (NASDAQ: ALBO) surged 9.4% to close at $18.23. Guggenheim initiated coverage on Albireo Pharma with a Buy rating and announced a price target of $55.
- Snap Inc . (NYSE: NYSE:SNAP) rose 9.3% to close at $12.53 on continued strength after a recent internal memo obtained by The Verge suggested the company is aiming to reach $6 billion in revenue and 450 million users by next year.
- Intapp, Inc. (NASDAQ: INTA) rose 8.5% to close at $15.95 after the company reported better-than-expected Q4 results and issued guidance above estimates.
- GameStop Corp . (NYSE: NYSE:GME) rose 7.5% to close at $25.83 after the company reported better-than-expected earnings for its second quarter and also announced a partnership with cryptocurrency exchange FTX to bring more customers to the digital asset space.
- Zillow Group, Inc. (NASDAQ: ZG) gained 6.3% to close at $37.58 after Jefferies maintained a Buy rating on the stock and raised its price target from $48 to $50.
- Troika Media Group, Inc. (NASDAQ: TRKA) dipped 26.8% to settle at $0.4756 on Thursday after declining around 6% on Wednesday.
- Great Panther Mining Limited (NYSE: GPL) shares tumbled 25.9% to close at $0.2396. The company recently announced it has determined to file a notice of intention to make a proposal under the Bankruptcy and Insolvency Act, which will provide credit protection.
- PlayAGS, Inc. (NYSE: AGS) shares fell 20.2% to close at $6.07.
- Ensysce Biosciences, Inc. (NASDAQ: ENSC) fell 19.7% to close at $0.3313.
- a.k.a. Brands Holding Corp. (NYSE: AKA) dipped 19.2% to close at $2.36.
- Globalstar, Inc. (NYSE: GSAT) fell 18.9% to settle at $1.67 amid possible profit taking. The stock gained on Wednesday after the company announced it will be the satellite operator for Apple (NASDAQ:AAPL) satellite-enabled services.
- Biophytis S.A. (NASDAQ: BPTS) declined 17.7% to close at $0.9139. Biophytis recently announced top-line results from its phase 2-3 COVA clinical study evaluating Sarconeos in the treatment of COVID-19-related respiratory failure.
- Golden Path Acquisition Corporation (NASDAQ: GPCO) fell 16.7% to close at $7.40.
- VirnetX Holding Corp (NYSE: VHC) dipped 16.6% to close at $1.56.
- Addentax Group Corp. (NASDAQ: ATXG) dropped 15.7% to settle at $5.22.
- Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) fell 15.5% to close at $30.76.
- Nogin, Inc. (NASDAQ: NOGN) declined 15.4% to close at $1.71.
- Bilibili Inc. (NASDAQ: BILI) fell 15% to close at $20.07 following Q2 results.
- Skillsoft Corp. (NYSE: SKIL) fell 14.9% to close at $2.29 after the company posted downbeat quarterly sales and authorized a $30 million share buyback.
- Tandy Leather Factory Inc. (NASDAQ: TLF) fell 14.8% to close at $5.24 following uplisting of its stock.
- Dave & Buster's Entertainment, Inc. (NASDAQ: PLAY) dropped 14.2% to close at $37.72. While the company reported better-than-expected Q2 results, operating income dropped from 2021 levels.
- Innovid Corp. (NYSE: CTV) fell 13.9% to close at $3.17.
- Genenta Science S.p.A. (NASDAQ: GNTA) fell 13.5% to close at $4.60.
- Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares fell 13% to close at $0.5449. Chembio Diagnostics filed for potential stock offering.
- Cohn Robbins Holdings Corp. (NYSE: CRHC) dipped 12.8% to close at $7.96.
- MasterCraft Boat Holdings, Inc. (NASDAQ: MCFT) fell 12.7% to close at $20.74. The company posted upbeat quarterly earnings, but issued weak FY23 forecast. MasterCraft Boat also sold its NauticStar business to Iconic Marine Group.
- Mercer International Inc. (NASDAQ: MERC) dipped 12.5% to close at $14.07.
- The Lovesac Company (NASDAQ: LOVE) dropped 12.4% to close at $26.18 following Q2 results.
- Erasca, Inc. (NASDAQ: ERAS) fell 11.3% to close at $8.34. Erasca announced preliminary Phase 1/1b monotherapy data for ERK1/2 inhibitor ERAS-007 and SHP2 inhibitor ERAS-601 in BRAF-driven and RAS/MAPK-altered solid tumors.
- Sylvamo Corporation (NYSE: SLVM) declined 9.8% to close at $36.50.
- Sabre Corporation (NASDAQ: SABR) dropped 9.5% to close at $6.54 after Mizuho maintained a Neutral rating on the stock and lowered its price target from $8 to $7.
- Mullen Automotive, Inc. (NASDAQ: MULN) fell 9.3% to close at $0.61 after the company announced it has acquired a 60% controlling interest in Bollinger Motors for $148.2 million in cash and stock.
- American Eagle Outfitters , Inc. (NYSE: NYSE:AEO) shares fell 8.7% to settle at $10.58 after the company reported worse-than-expected Q2 EPS results.
- McCormick (NYSE:MKC) & Company, Incorporated (NYSE: MKC) fell 6.7% to close at $79.30. McCormick said it expects third-quarter FY22 sales to increase about 3% year-on-year and 6% in constant currency.
- Wayfair Inc. (NYSE: W) fell 3.7% to close at $48.81 after the company reported a proposed offering of $600 million convertible senior notes.
- Grid Dynamics Holdings, Inc. (NASDAQ: GDYN) fell 3.6% to close at $19.08 after the company priced its common stock offering of about 5.71 million shares at $17.50 per share.
Read at Benzinga